Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

MMGs and Artifacts

This page contains Message Mapping Guides (MMGs) that are final or in development for HL7 case notifications to NNDSS.

MMG Development Stages

  • Stage I – Draft MMGs: These draft guides are under review by local, state, and territorial public health surveillance staff during their open comment periods.
  • Stage II – Pilot Test-ready Draft MMGs and Artifacts: These draft guides and artifacts are provided to local, state, and territorial jurisdictions that are part of the NMI pilot testing process. They also are posted here for other jurisdictions that would like the opportunity to examine them.
  • Stage III – Final MMGs: These guides are final and have been published as they are available.
Expand All expand all Collapse All collapse all

Babesiosis (Stage I-Draft):
The 30-day comment period for the Draft Babesiosis MMG closed on July 27, 2016. Comments are no longer being accepted through the Electronic Data Exchange mailbox.

Congenital Rubella Syndrome (Stage I – Draft):
The 30-day comment period for the Draft Congenital Rubella Syndrome MMG closed on November 18, 2016. Comments are no longer being accepted through the Electronic Data Exchange mailbox.

Malaria (Stage I-Draft)
The 30-day comment period for the Draft Malaria MMG closed on July 22, 2016. Comments are no longer being accepted through the Electronic Data Exchange mailbox.

Measles (Stage I-Draft):
The 30-day comment period for the Draft Measles MMG closed on August 15, 2016. Comments are no longer being accepted through the Electronic Data Exchange mailbox.

Rubella (Stage I – Draft):
The 30-day comment period for the Draft Rubella MMG closed on November 18, 2016. Comments are no longer being accepted through the Electronic Data Exchange mailbox.

Measles (Stage I-Draft):
The 30-day comment period for the Draft Measles MMG closed on August 15, 2016. Comments are no longer being accepted through the Electronic Data Exchange mailbox.

Varicella (Stage I-Draft)
The 2-month review period for the 30-day external review reconciled feedback and Draft Varicella MMG from which the feedback was based closed on February 9, 2017.

CAVEAT

MMGs in Stages I and II are considered draft and may be revised until the time they are finalized.

Those jurisdictions selected for pilot testing of the test-ready versions (Stage II) of the MMGs should wait until contacted by the NMI Technical Assistance Team before using the test-ready MMGs, before implementing surveillance information system changes, and before submitting test messages to CDC.

All other jurisdictions should wait until the final MMGs (Stage III) are published to update their surveillance information systems and start building messages. Please do not submit notifications using the new MMGs before CDC announces the date on which we will be ready to receive data in the new format.

* This Link takes you to the "View" in PHIN VADS of all the value sets included in this MMG. The latest "View" is labeled the "Current" version. On the "View" page in PHIN VADS, you can subscribe to future updates to value sets in the View. For more information about PHIN VADS "Views", please refer to this presentation, which was presented as a hot topic on the June 16, 2016 eSHARE call.

Top